Oaktree Acquisition Corp. III Life Sciences (OACC) stock
OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026
$10.72+0.02 (+0.19%)
Close on Nov 17, 2026Market cap $263.53MP/E –Yield –
Oaktree Acquisition Corp. III Life Sciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
No price to sales ratio figures for Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?